Gut microbiota, tight junction protein expression, intestinal resistance, bacterial translocation and mortality following cholestasis depend on the genetic background of the host

Gut Microbes

Volumn 4, Issue 4, 2013, Pages 292-305

  Alaish, Samuel M ^a   Smith, Alexis D ^a   Timmons, Jennifer ^a   Greenspon, Jose ^a   Eyvazzadeh, Daniel ^a   Murphy, Ebony ^a   Shea Donahue, Terez ^a   Cirimotich, Shana ^a   Mongodin, Emmanuel ^a   Zhao, Aiping ^a   Fasano, Alessio ^a   Nataro, James P ^b   Cross, Alan ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Bacterial translocation; Bile duct ligation; Cholestasis; Interferon gamma; Intestinal microbiota; Transepithelial electric resistance

Indexed keywords

CD14 ANTIGEN; CLAUDIN 2; GAMMA INTERFERON; MESSENGER RNA; OCCLUDIN; RNA 16S; TIGHT JUNCTION PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTERIAL TRANSLOCATION; BILE DUCT LIGATION; CHOLESTASIS; CONTROLLED STUDY; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETIC STRAIN; HOST PATHOGEN INTERACTION; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; MESENTERY LYMPH NODE; MORTALITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PYROSEQUENCING; SHAM PROCEDURE; WESTERN BLOTTING;

BACTERIAL TRANSLOCATION; BILE DUCT LIGATION; CHOLESTASIS; INTERFERON-GAMMA; INTESTINAL MICROBIOTA; TRANSEPITHELIAL ELECTRIC RESISTANCE;

ANIMALS; BACTEREMIA; BACTERIAL TRANSLOCATION; CHOLESTASIS; GASTROINTESTINAL TRACT; GENETIC PREDISPOSITION TO DISEASE; MALE; MICE; MICE, INBRED A; MICE, INBRED C57BL; TIGHT JUNCTION PROTEINS;

EID: 84880502734     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.24706     Document Type: Article

References (57)

1. De Maio A, Torres MB, Reeves RH. Genetic determinants influencing the response to injury, inflammation, and sepsis. Shock 2005; 23:11-17; PMID:15614125; http://dx.doi.org/10.1097/01.shk.0000144134.03598.c5.
2. De Maio A, Mooney ML, Matesic LE, Paidas CN, Reeves RH. Genetic component in the inflammatory response induced by bacterial lipopolysaccha-ride. Shock 1998; 10:319-323; PMID:9840645; http://dx.doi.org/10.1097/00024382-199811000-00002.
3. Stewart D, Fulton WB, Wilson C, Monitto CL, Paidas CN, Reeves RH, et al. Genetic contribution to the septic response in a mouse model. Shock 2002; 18:342-347; PMID:12392278; http://dx.doi.org/10.1097/00024382-200210000-00009.
4. Nishikawa F, Yoshikawa S, Harada H, Kita M, Kita E. The full expression of the ity phenotype in ityr mice requires C3 activation by Salmonella lipopolysaccha-ride. Immunology 1998; 95:640-647; PMID:9893057; http://dx.doi.org/10.1046/j.1365-2567.1998.00647.x.
5. Banus HA, Vandebriel RJ, de Ruiter H, Dormans JA, Nagelkerke NJ, Mooi FR, et al. Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology. Infect Immun 2006; 74:2596-2605; PMID:16622195; http://dx.doi.org/10.1128/IAI.74.5.2596-2605.2006.
6. Tuite A, Elias M, Picard S, Mullick A, Gros P. Genetic control of susceptibility to Candida albicans in susceptible A/J and resistant C57BL/6J mice. Genes Immun 2005; 6:672-682; PMID:16079897.
7. Hernandez-Valladares M, Naessens J, Nagda S, Musoke AJ, Rihet P, Ole-Moiyoi OK, et al. Comparison of pathology in susceptible A/J and resistant C57BL/6J mice after infection with different sub-strains of Plasmodium chabaudi. Exp Parasitol 2004; 108:134-141; PMID:15582510; http://dx.doi.org/10.1016/j.exppara.2004.07.011.
8. Czuprynski CJ, Faith NG, Steinberg H. A/J mice are susceptible and C57BL/6 mice are resistant to Listeria monocytogenes infection by intragastric inoculation. Infect Immun 2003; 71:682-689; PMID:12540546; http://dx.doi.org/10.1128/IAI.71.2.682-689.2003.
9. Hughes MA, Green CS, Lowchyj L, Lee GM, Grippe VK, Smith MF, et al. MyD88-dependent signaling contributes to protection following Bacillus anthracis spore challenge of mice: implications for Toll-like receptor signaling. Infect Immun 2005; 73:7535-7540; PMID:16239556; http://dx.doi.org/10.1128/IAI.73.11.7535-7540.2005.
10. Georgiev P, Jochum W, Heinrich S, Jang JH, Nocito A, Dahm F, et al. Characterization of time-related changes after experimental bile duct ligation. Br J Surg 2008; 95:646-656; PMID:18196571; http://dx.doi.org/10.1002/bjs.6050.
11. Alaish SM, Torres M, Ferlito M, Sun CC, De Maio A. The severity of cholestatic injury is modulated by the genetic background. Shock 2005; 24:412-416; PMID:16247325; http://dx.doi.org/10.1097/01.shk.0000183392.83272.97.
12. Hollander D. Crohn's disease--a permeability disorder of the tight junction? Gut 1988; 29:1621-1624; PMID:3065154; http://dx.doi.org/10.1136/gut.29.12.1621.
13. Murphy MS, Eastham EJ, Nelson R, Pearson AD, Laker M F. Intestinal permeability in Crohn's disease. Arch Dis Child 1989; 64:321-325; PMID:2495775; http://dx.doi.org/10.1136/adc.64.3.321.
14. Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med 1986; 105:883-885; PMID:3777713; http://dx.doi.org/10.7326/0003-4819-105-6-883.
15. Pascual S, Such J, Esteban A, Zapater P, Casellas JA, Aparicio JR, et al. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology 2003; 50:1482-1486; PMID:14571769.
16. Campillo B, Pernet P, Bories PN, Richardet J P, Devanlay M, Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 1999; 11:755-759; PMID:10445796; http://dx.doi.org/10.1097/00042737-199907000-00013.
17. Li Q, Zhang Q, Wang C, Liu X, Li N, Li J. Disruption of tight junctions during polymicrobial sepsis in vivo. J Pathol 2009; 218:210-221; PMID:19235836; http://dx.doi.org/10.1002/path.2525.
18. Zhou P, Li E, Shea-Donohue T, Singer SM. Tumour necrosis factor contributes to protection against Giardia lamblia infection in mice. Parasite Immunol 2007; 29:367-374; PMID:17576366; http://dx.doi.org/10.1111/j.1365-3024.2007.00953.x.
19. Hyun CS, Chen C W, Shinowara NL, Palaia T, Fallick FS, Martello LA, et al. Morphological factors influencing transepithelial conductance in a rabbit model of ileitis. Gastroenterology 1995; 109:13-23; PMID:7797012; http://dx.doi.org/10.1016/0016-5085(95)90264-3.
20. Pérez-Paramo M, Muñoz J, Albillos A, Freile I, Portero F, Santos M, et al. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 2000; 31:43-48; PMID:10613726; http://dx.doi.org/10.1002/hep.510310109.
21. Clayburgh DR, Shen L, Turner JR. A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 2004; 84:282-291; PMID:14767487; http://dx.doi.org/10.1038/labinvest.3700050.
22. Madara JL, Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial mono-layers. J Clin Invest 1989; 83:724-727; PMID:2492310; http://dx.doi.org/10.1172/JCI113938.
23. Marano CW, Lewis SA, Garulacan LA, Soler A P, Mullin JM. Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line. J Membr Biol 1998; 161:263-274; PMID:9493132; http://dx.doi.org/10.1007/s002329900333.
24. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, et al. Proinflammatory cyto-kines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003; 171:6164-6172; PMID:14634132.
25. Youakim A, Ahdieh M. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol 1999; 276:G1279-G1288; PMID:10330020.
26. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gno-tobiotic mouse model. Infect Immun 1979; 23:403-411; PMID:154474.
27. Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994; 21:792-796; PMID:7890896; http://dx.doi.org/10.1016/S0168-8278(94)80241-6.
28. Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 1995; 108:1835-1841; PMID:7768390; http://dx.doi.org/10.1016/0016-5085(95)90147-7.
29. Llovet JM, Bartolí R, March F, Planas R, Viñado B, Cabré E, et al. Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence. J Hepatol 1998; 28:307-313; PMID:9580278; http://dx.doi.org/10.1016/0168-8278(88)80018-7.
30. Coopersmith CM, Stromberg PE, Dunne WM, Davis CG, Amiot DM, Buchman TG, et al. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 2002; 287:1716-1721; PMID:11926897; http://dx.doi.org/10.1001/jama.287.13.1716.
31. El Asmar R, Panigrahi P, Bamford P, Berti I, Not T, Coppa GV, et al. Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology 2002; 123:1607-1615; PMID:12404235; http://dx.doi.org/10.1053/gast.2002.36578.
32. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254; PMID:942051; http://dx.doi.org/10.1016/0003-2697(76)90527-3.
33. Zupancic ML, Cantarel BL, Liu Z, Drabek E F, Ryan KA, Cirimotich S, et al. Analysis of the gut micro-biota in the old order Amish and its relation to the metabolic syndrome. PLoS One 2012; 7:e43052; PMID:22905200; http://dx.doi.org/10.1371/journal.pone.0043052.
34. Sewnath ME, Van Der Poll T, Van Noorden CJF, Ten Kate FJ, Gouma DJ. Endogenous interferon γ protects against cholestatic liver injury in mice. Hepatology 2002; 36:1466-1477; PMID:12447873.
35. Rees LE, Cogan TA, Dodson AL, Birchall MA, Bailey M, Humphrey TJ. Campylobacter and IFNgamma interact to cause a rapid loss of epithelial barrier integrity. Inflamm Bowel Dis 2008; 14:303-309; PMID:18050297; http://dx.doi.org/10.1002/ibd.20325.
36. Köhler H, Sakaguchi T, Hurley B P, Kase BA, Reinecker HC, McCormick BA. Salmonella enterica serovar Typhimurium regulates intercellular junction proteins and facilitates transepithelial neutrophil and bacterial passage. Am J Physiol Gastrointest Liver Physiol 2007; 293:G178-G187; PMID:17615177; http://dx.doi.org/10.1152/ajpgi.00535.2006.
37. Howe KL, Reardon C, Wang A, Nazli A, McKay DM. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability. Am J Pathol 2005; 167:1587-1597; PMID:16314472; http://dx.doi.org/10.1016/S0002-9440(10)61243-6.
38. Yang R, Harada T, Li J, Uchiyama T, Han Y, Englert JA, et al. Bile modulates intestinal epithelial barrier function via an extracellular signal related kinase 1/2 dependent mechanism. Intensive Care Med 2005; 31:709-717; PMID:15782315; http://dx.doi.org/10.1007/s00134-005-2601-9.
39. Wells CL, Hess DJ, Erlandsen SL. Impact of the indigenous flora in animal models of shock and sepsis. Shock 2004; 22:562-568; PMID:15545829; http://dx.doi.org/10.1097/01.shk.0000145935.24344.2d.
40. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005; 102:11070-11075; PMID:16033867; http://dx.doi.org/10.1073/pnas.0504978102.
41. Fouts DE, Torralba M, Nelson KE, Brenner DA, Schnabl B. Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease. J Hepatol 2012; 56:1283-1292; PMID:22326468; http://dx.doi.org/10.1016/j.jhep.2012.01.019.
42. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444:1027-1031; PMID:17183312; http://dx.doi.org/10.1038/nature05414.
43. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008; 3:213-223; PMID:18407065; http://dx.doi.org/10.1016/j.chom.2008.02.015.
44. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56:1761-1772; PMID:17456850; http://dx.doi.org/10.2337/db06-1491.
45. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57:1470-1481; PMID:18305141; http://dx.doi.org/10.2337/db07-1403.
46. Azcarate-Peril MA, Foster DM, Cadenas MB, Stone MR, Jacobi SK, Stauffer SH, et al. Acute necrotiz-ing enterocolitis of preterm piglets is characterized by dysbiosis of ileal mucosa-associated bacteria. Gut Microbes 2011; 2:234-243; PMID:21983069; http://dx.doi.org/10.4161/gmic.2.4.16332.
47. Mai V, Young CM, Ukhanova M, Wang X, Sun Y, Casella G, et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One 2011; 6:e20647; PMID:21674011; http://dx.doi.org/10.1371/journal.pone.0020647.
48. Deitch EA, Sittig K, Li M, Berg R, Specian RD. Obstructive jaundice promotes bacterial transloca-tion from the gut. Am J Surg 1990; 159:79-84; PMID:2136788; http://dx.doi.org/10.1016/S0002-9610(05)80610-5.
49. Slocum MM, Sittig KM, Specian RD, Deitch EA. Absence of intestinal bile promotes bacterial transloca-tion. Am Surg 1992; 58:305-310; PMID:1622012.
50. Conus S, Simon HU. Cathepsins: key modulators of cell death and inflammatory responses. Biochem Pharmacol 2008; 76:1374-1382; PMID:18762176; http://dx.doi.org/10.1016/j.bcp.2008.07.041.
51. Tulone C, Tsang J, Prokopowicz Z, Grosvenor N, Chain B. Natural cathepsin E deficiency in the immune system of C57BL/6J mice. Immunogenetics 2007; 59:927-935; PMID:18000662; http://dx.doi.org/10.1007/s00251-007-0256-0.
52. Bennett K, Levine T, Ellis JS, Peanasky RJ, Samloff IM, Kay J, et al. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur J Immunol 1992; 22:1519-1524; PMID:1601038; http://dx.doi.org/10.1002/eji.1830220626.
53. Inagaki T, Moschetta A, Lee YK, Peng L, Zhao G, Downes M, et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A 2006; 103:3920-3925; PMID:16473946.
54. Vavassori P, Mencarelli A, Renga B, Distrutti E, Fiorucci SJ. The bile acid receptor FXR is a modulator of intestinal innate immunity. Immunol 2009; 183:6251-6261; http://dx.doi.org/10.4049/jimmunol.0803978.
55. Zeissig S, Bürgel N, Günzel D, Richter J, Mankertz J, Wahnschaffe U, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007; 56:61-72; PMID:16822808; http://dx.doi.org/10.1136/gut.2006.094375.
56. Amasheh M, Grotjohann I, Amasheh S, Fromm A, Soderholm JD, Zeitz M, et al. Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: A novel model for studying the pathomechanisms of inflammatory bowel disease cytokines. Scand J Gastroenterol 2009; 4:1-10; PMID:19658020.
57. Sabuncuoglu MZ, Kismet K, Kilicoglu SS, Kilicoglu B, Erel S, Muratoglu S, et al. Propolis reduces bacterial translocation and intestinal villus atrophy in experimental obstructive jaundice. World J Gastroenterol 2007; 13:5226-5231; PMID:17876893.